Fireside Chat // China’s biomanufacturing surge: Where capital is flowing, and what it means for the rest of the world

29 Oct 2026
Main Auditorium
Main Stage

China’s biomanufacturing ecosystem is scaling rapidly, combining deep scientific capabilities, manufacturing infrastructure and growing investment to accelerate innovation across the bioeconomy. As these strengths increasingly spill into agricultural and food biotechnology, where are Chinese companies and investors placing their bets? And what does China’s rise mean for global partnerships, investment and competition as the next generation of biomanufacturing moves towards commercial scale?

Host
Becky Zhao
Becky Zhao, Head of International Cooperation - SHANGHAI SYNBIO INNOVATION CENTER (SSIC), China
Speakers
Lucy (Lu) Dai
Lucy (Lu) Dai, Managing Partner - CHENGWEI CAPITAL SYNTHETIC BIOLOGY FUND, China
Jin Yuchen
Jin Yuchen, Managing Director - DAOTONG INVESTMENT, China
Jacky Yang
Jacky Yang, Senior Partner and Managing Director - FROST & SULLIVAN CHINA, China